Works by Chae-Yong Kim

Results: 98
    1
    2
    3
    4

    Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study).

    Published in:
    Cancer Research & Treatment, 2022, v. 54, n. 2, p. 396, doi. 10.4143/crt.2021.393
    By:
    • Ahn, Grace S.;
    • Kihwan Hwang;
    • Tae Min Kim;
    • Chul Kee Park;
    • Jong Hee Chang;
    • Tae-Young Jung;
    • Jin Hee Kim;
    • Do-Hyun Nam;
    • Se-Hyuk Kim;
    • Heon Yoo;
    • Yong-Kil Hong;
    • Eun-Young Kim;
    • Dong-Eun Lee;
    • Jungnam Joo;
    • Yu Jung Kim;
    • Gheeyoung Choe;
    • Byung Se Choi;
    • Seok-Gu Kang;
    • Jeong Hoon Kim;
    • Chae-Yong Kim
    Publication type:
    Article
    5

    Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study).

    Published in:
    Cancer Research & Treatment, 2020, v. 52, n. 2, p. 505, doi. 10.4143/crt.2019.421
    By:
    • Kihwan Hwang;
    • Tae Min Kim;
    • Chul-Kee Park;
    • Jong Hee Chang;
    • Tae-Young Jung;
    • Jin Hee Kim;
    • Do-Hyun Nam;
    • Se-Hyuk Kim;
    • Heon Yoo;
    • Yong-Kil Hong;
    • Eun-Young Kim;
    • Dong-Eun Lee;
    • Jungnam Joo;
    • Yu Jung Kim;
    • Gheeyoung Choe;
    • Byung Se Choi;
    • Seok-Gu Kang;
    • Jeong Hoon Kim;
    • Chae-Yong Kim
    Publication type:
    Article
    6
    7

    Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.

    Published in:
    Cancer Research & Treatment, 2017, v. 49, n. 1, p. 193, doi. 10.4143/crt.2015.473
    By:
    • Byung Sup Kim;
    • Ho Jun Seo;
    • Do-Hyun Nam;
    • Chul-Kee Park;
    • Il Han Kim;
    • Tae Min Kim;
    • Jeong Hoon Kim;
    • Young Hyun Cho;
    • Sang Min Yoon;
    • Jong Hee Chang;
    • Seok-Gu Kang;
    • Eui Hyun Kim;
    • Chang-Ok Suh;
    • Tae-Young Jung;
    • Kyung-Hwa Lee;
    • Chae-Yong Kim;
    • In Ah Kim;
    • Chang-Ki Hong;
    • Heon Yoo;
    • Jin Hee Kim
    Publication type:
    Article
    8
    9

    Role of induction chemotherapy in advanced‐stage olfactory neuroblastoma.

    Published in:
    International Forum of Allergy & Rhinology, 2024, v. 14, n. 12, p. 1882, doi. 10.1002/alr.23428
    By:
    • Cho, Sung‐Woo;
    • Keam, Bhumsuk;
    • Lee, Keun‐Wook;
    • Kim, Ji‐Won;
    • Han, Doo Hee;
    • Kim, Hyun Jik;
    • Kim, Jeong‐Whun;
    • Kim, Dong‐Young;
    • Rhee, Chae‐Seo;
    • Bae, Yun Jung;
    • Kim, Ji‐Hoon;
    • Eom, Keun‐Yong;
    • Wu, Hong‐Gyun;
    • Kim, Yong Hwy;
    • Kim, Chae‐Yong;
    • Paek, Sun Ha;
    • Kim, Hyojin;
    • Won, Tae‐Bin
    Publication type:
    Article
    10
    11
    12

    Perspectives on key articles in neurosurgery.

    Published in:
    2012
    By:
    • Lim, Michael;
    • Sherman, Jonathan H.;
    • Wang, Vincent Y.;
    • Smith, Zachary A.;
    • Jin Mo Cho;
    • Colen, Chaim B.;
    • Chae Yong Kim;
    • Zada, Gabriel;
    • Li, Gordon;
    • Yang, Isaac
    Publication type:
    Abstract
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial.

    Published in:
    Journal of Neuro-Oncology, 2011, v. 103, n. 3, p. 595, doi. 10.1007/s11060-010-0427-y
    By:
    • Kim, Il;
    • Park, Chul-Kee;
    • Heo, Dae;
    • Kim, Chae-Yong;
    • Rhee, Chang;
    • Nam, Do-Hyun;
    • Lee, Seung;
    • Han, Jung;
    • Lee, Se-Hoon;
    • Kim, Tae;
    • Kim, Dong-Wan;
    • Kim, Jeong;
    • Paek, Sun;
    • Kim, Dong;
    • Kim, In;
    • Kim, Yu;
    • Kim, Jee;
    • Park, Byung-Joo;
    • Jung, Hee-Won
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug‐carrier molecule for the treatment of glioblastoma.

    Published in:
    Chemical Biology & Drug Design, 2023, v. 101, n. 3, p. 696, doi. 10.1111/cbdd.14171
    By:
    • Cooper, Elizabeth;
    • Choi, Peter J.;
    • Hwang, Kihwan;
    • Nam, Kyung M.;
    • Kim, Chae‐Yong;
    • Shaban, Tina;
    • Schweder, Patrick;
    • Mee, Edward;
    • Correia, Jason;
    • Turner, Clinton;
    • Faull, Richard L. M.;
    • Denny, William A.;
    • Noguchi, Katsuya;
    • Dragunow, Mike;
    • Jose, Jiney;
    • Park, Thomas I.‐H.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50